| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.0045 | 1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.0092 | 1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.01 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |